Literature DB >> 24254804

PNist: interactive volumetric measurements of plexiform neurofibromas in MRI scans.

Lior Weizman1, Dina Helfer, Dafna Ben Bashat, Li-Tal Pratt, Leo Joskowicz, Shlomi Constantini, Ben Shofty, Liat Ben Sira.   

Abstract

PURPOSE: Volumetric measurements of plexiform neurofibromas (PNs) are time consuming and error prone, as they require the delineation of the PN boundaries, which is mostly impractical in the daily clinical setup. Accurate volumetric measurements are seldom performed for these tumors mainly due to their great dispersion, size and multiple locations. This paper presents a semiautomatic method for segmentation of PN from STIR MRI scans.
METHODS: Plexiform neurofibroma interactive segmentation tool (PNist) is a new tool to segment PNs in STIR MRI scans. The method is based on histogram tumor models computed from a training set.
RESULTS: Experimental results from 28 datasets show an average absolute volume difference of 6.8 % with an average user time of approximately 7 min versus more than 13 min with manual delineation. In complex cases, the PNist user time is less than half in compared to state-of-the-art tools.
CONCLUSIONS: PNist is a new method for the semiautomatic segmentation of PN lesions. Its simplicity and reliability make it unique among other state-of-the-art methods. It has the potential to become a clinical tool that allows the reliable evaluation of PN burden and progression.

Entities:  

Mesh:

Year:  2013        PMID: 24254804     DOI: 10.1007/s11548-013-0961-0

Source DB:  PubMed          Journal:  Int J Comput Assist Radiol Surg        ISSN: 1861-6410            Impact factor:   2.924


  14 in total

1.  New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada.

Authors:  P Therasse; S G Arbuck; E A Eisenhauer; J Wanders; R S Kaplan; L Rubinstein; J Verweij; M Van Glabbeke; A T van Oosterom; M C Christian; S G Gwyther
Journal:  J Natl Cancer Inst       Date:  2000-02-02       Impact factor: 13.506

2.  MRI growth patterns of plexiform neurofibromas in patients with neurofibromatosis type 1.

Authors:  V F Mautner; M Hartmann; L Kluwe; R E Friedrich; C Fünsterer
Journal:  Neuroradiology       Date:  2006-01-24       Impact factor: 2.804

3.  Plexiform neurofibromas in children with neurofibromatosis type 1: frequency and associated clinical deficits.

Authors:  Rosa Nguyen; Lan Kluwe; Carsten Fuensterer; Michael Kentsch; Reinhard Edgar Friedrich; Victor-Felix Mautner
Journal:  J Pediatr       Date:  2011-05-31       Impact factor: 4.406

4.  Response criteria for phase II studies of supratentorial malignant glioma.

Authors:  D R Macdonald; T L Cascino; S C Schold; J G Cairncross
Journal:  J Clin Oncol       Date:  1990-07       Impact factor: 44.544

5.  Interactive segmentation of plexiform neurofibroma tissue: method and preliminary performance evaluation.

Authors:  Lior Weizman; Lior Hoch; Dafna Ben Bashat; Leo Joskowicz; Li-tal Pratt; Shlomi Constantini; Liat Ben Sira
Journal:  Med Biol Eng Comput       Date:  2012-06-16       Impact factor: 2.602

6.  Interobserver reproducibility of volumetric MR imaging measurements of plexiform neurofibromas.

Authors:  Tina Young Poussaint; Diego Jaramillo; Yuchiao Chang; Bruce Korf
Journal:  AJR Am J Roentgenol       Date:  2003-02       Impact factor: 3.959

7.  Longitudinal study of neurofibromatosis 1 associated plexiform neurofibromas.

Authors:  T Tucker; J M Friedman; R E Friedrich; R Wenzel; C Fünsterer; V-F Mautner
Journal:  J Med Genet       Date:  2008-10-17       Impact factor: 6.318

8.  Tumor burden in patients with neurofibromatosis types 1 and 2 and schwannomatosis: determination on whole-body MR images.

Authors:  Wenli Cai; Ara Kassarjian; Miriam A Bredella; Gordon J Harris; Hiroyuki Yoshida; Victor F Mautner; Ralph Wenzel; Scott R Plotkin
Journal:  Radiology       Date:  2009-03       Impact factor: 11.105

9.  Measuring response in solid tumors: comparison of RECIST and WHO response criteria.

Authors:  Joon Oh Park; Soon Il Lee; Seo Young Song; Kihyun Kim; Won Seog Kim; Chul Won Jung; Young Suk Park; Young-Hyuk Im; Won Ki Kang; Mark Hong Lee; Kyung Soo Lee; Keunchil Park
Journal:  Jpn J Clin Oncol       Date:  2003-10       Impact factor: 3.019

Review 10.  Neurofibromatosis type 1 revisited.

Authors:  Virginia C Williams; John Lucas; Michael A Babcock; David H Gutmann; Bruce Korf; Bernard L Maria
Journal:  Pediatrics       Date:  2009-01       Impact factor: 7.124

View more
  4 in total

1.  Radiomic biomarkers informative of cancerous transformation in neurofibromatosis-1 plexiform tumors.

Authors:  J Uthoff; F A De Stefano; K Panzer; B W Darbro; T S Sato; R Khanna; D E Quelle; D K Meyerholz; J Weimer; J C Sieren
Journal:  J Neuroradiol       Date:  2018-06-27       Impact factor: 3.447

2.  MR diffusion-weighted imaging-based subcutaneous tumour volumetry in a xenografted nude mouse model using 3D Slicer: an accurate and repeatable method.

Authors:  Zelan Ma; Xin Chen; Yanqi Huang; Lan He; Cuishan Liang; Changhong Liang; Zaiyi Liu
Journal:  Sci Rep       Date:  2015-10-22       Impact factor: 4.379

3.  DINs: Deep Interactive Networks for Neurofibroma Segmentation in Neurofibromatosis Type 1 on Whole-Body MRI.

Authors:  Jian-Wei Zhang; Wei Chen; K Ina Ly; Xubin Zhang; Fan Yan; Justin Jordan; Gordon Harris; Scott Plotkin; Pengyi Hao; Wenli Cai
Journal:  IEEE J Biomed Health Inform       Date:  2022-02-04       Impact factor: 5.772

4.  Image segmentation of plexiform neurofibromas from a deep neural network using multiple b-value diffusion data.

Authors:  Chang Y Ho; John M Kindler; Scott Persohn; Stephen F Kralik; Kent A Robertson; Paul R Territo
Journal:  Sci Rep       Date:  2020-10-20       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.